Baseline basophil activation and early suppression is associated with clinical outcome after peanut sublingual immunotherapy基线嗜碱性粒细胞活化及早期抑制与花生舌下免疫疗法的临床结局相关Journal of Allergy and Clinical ImmunologyIF11.22025-04-150PRE
Desensitization and remission after peanut sublingual immunotherapy in 1-to 4-year-old peanut-allergic children: A randomized, placebo-controlled trialJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22024-01-0117OA
Open-label study of the efficacy, safety, and durability of peanut sublingual immunotherapy in peanut-allergic childrenJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22023-06-0122OAAI
Kinetics of basophil hyporesponsiveness during short-course peanut oral immunotherapyJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22022-11-014OAAI
Novel peanut-specific human IgE monoclonal antibodies enable screens for inhibitors of the effector phase in food allergyFRONTIERS IN IMMUNOLOGYIF5.92022-09-296OAAI
A Novel Allergen-Specific Immune Signature-Directed Approach to Dietary Elimination in Eosinophilic EsophagitisCLINICAL AND TRANSLATIONAL GASTROENTEROLOGYIF32019-12-0133OAAI
Long-term sublingual immunotherapy for peanut allergy in children: Clinical and immunologic evidence of desensitizationJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22019-11-0187OAAI
Genetic diversity between mouse strains allows identification of the CC027/GeniUnc strain as an orally reactive model of peanut allergyJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22019-03-0141OAAI
Blocking antibodies induced by peanut oral and sublingual immunotherapy suppress basophil activation and are associated with sustained unresponsivenessCLINICAL AND EXPERIMENTAL ALLERGYIF5.22018-11-2933OAAI
High- and low-dose oral immunotherapy similarly suppress pro-allergic cytokines and basophil activation in young childrenCLINICAL AND EXPERIMENTAL ALLERGYIF5.22018-09-1845OAAI
Low and High Dose Peanut Oral Immunotherapy (OIT) Similarly Suppress Th2 Cytokine and Basophil Activation ResponsesJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22017-02-010OAAI
Antigen Absorption is Correlated With Allergic Reaction Severity Upon Oral Peanut Challenge in MiceJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22017-02-010OAAI
Six month course of peanut OIT leads to suppression of basophil activation which begins to wane within four weeks after OIT is stoppedJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22017-02-010PREAI
Early oral immunotherapy in peanut-allergic preschool children is safe and highly effectiveJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22017-01-01287OAAI
Food-specific igG4 is associated with eosinophilic esophagitisJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22016-10-0192OAAI
Basophil Activation and Peanut-Specific IgE Are Not Predictors of Threshold Dose during a Double-Blind Placebo-Controlled Food Challenge (DBPCFC)JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22016-02-010PREAI
Food-Specific IgG4 Is Associated with Eosinophilic EsophagitisJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22016-02-013OAAI
Sublingual Immunotherapy (SLIT) Regulates the Expression of Transcription Factors and Interleukins in Peanut Allergic ChildrenJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22016-02-011OAAI
Oral Tolerance and Unresponsiveness to Allergen Challenge after Immunotherapy Are Not Associated with a Change in B10 Cell Number in MiceJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22015-02-010PREAI
Peanut Sublingual Immunotherapy (SLIT) Results in Sustained Unresponsiveness in a Subset of Peanut Allergic ChildrenJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22015-02-012OAAI